 |
|
|
|
|
|
|
|
 |
Results for 'Molecular Diagnostics: Transforming the Pharmaceutical Market' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Personalized Medicine
|
August 2007 |
£990 |
50 % |
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
|
August 2001 |
£815 |
49.5 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
March 2008 |
£1985 |
44 % |
Commercializing Molecular Diagnostics:
Products, Services, Companies and Global Market
|
July 2008 |
£1295 |
35 % |
Biomarkers
Technologies, Markets and Companies
|
March 2008 |
£1515 |
33 % |
Companion Diagnostics Markets
(A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)
|
June 2008 |
£1510 |
32.9 % |
Biomarkers & Related Tests for Molecular Diagnostics & Pharma/ Biotech R&D
Companies, Products & Worldwide Market, 2004-2009
|
July 2005 |
£940 |
32.55 % |
Innovations in Diagnostics
|
September 2006 |
£1495 |
31.85 % |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Reshaping Tomorrow's Diabetes Market
|
October 2005 |
£990 |
31 % |
Nanobiotechnology
|
March 2008 |
£1740 |
26 % |
DNA Sequencing and PCR Markets
|
July 2008 |
£1695 |
24.85 % |
Cytology and HPV Testing World Markets
|
July 2008 |
£1695 |
24.15 % |
Biomarkers: A Market Briefing
A Market Briefing
|
January 2007 |
£1005 |
24 % |
Molecular Diagnostics Markets
|
March 2008 |
£1690 |
23.8 % |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£890 |
23 % |
2007 The Worldwide Biochip & Equipment Market
|
August 2006 |
£655 |
22.5 % |
Becton-Dickinson Medical Device Company Intelligence Report
|
March 2007 |
£395 |
21 % |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2410 |
21 % |
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
April 2008 |
£1715 |
20.65 % |
Genomics World Markets
|
May 2008 |
£1715 |
20.65 % |
Medical Imaging Markets, Volume IV
Contrast Agents
|
February 2007 |
£1510 |
20.5 % |
Gene Expression Reagents Markets
|
April 2007 |
£990 |
19.6 % |
Avian Influenza
The Threatening Pandemic
|
August 2006 |
£990 |
18.55 % |
Opportunities in Indian Healthcare Sector
|
November 2006 |
£300 |
18.55 % |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£545 |
18.5 % |
Commercial Opportunities from Biomarkers
Transforming drug discovery, clinical development and molecular diagnostic
|
May 2006 |
£1495 |
18.2 % |
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
April 2008 |
£1715 |
17.85 % |
Nanotechnology
Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics
|
January 2008 |
£1995 |
17.85 % |
Oncogenomics
The Future of Cancer Care
|
January 2006 |
£1945 |
17.85 % |
Blood
The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
|
September 2006 |
£1970 |
17.5 % |
Contract Pharmaceutical Manufacturing, Research, and Packaging
|
August 2007 |
£2410 |
17.5 % |
Clinical Genomics
Impact of Genomic Technology on Clinical Trials and Medical Practice
|
May 2004 |
£1950 |
17.5 % |
Impact of Pharmacogenomics on Public Healthcare Policy
Educating Patients, Payors and Healthcare Providers
|
March 2008 |
£1995 |
17.15 % |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£600 |
17.15 % |
Cancer Diagnostic Testing World Markets
|
April 2008 |
£1715 |
16.8 % |
Innovative And Targeted Cancer Therapies
Key Technologies, New Applications And Leading Players
|
July 2007 |
£1495 |
16.5 % |
Altana AG Deals
Partneringdesk briefing
|
July 2005 |
£215 |
16.5 % |
Pharmaceutical Contract Manufacturing and Research
|
May 2005 |
£2255 |
16.45 % |
Biomarkers and Tests for Pharma/ Biotech R&D
Companies, Products and Worldwide Market, 2006-2011
|
June 2007 |
£1290 |
16.45 % |
World Enzymes
Study # 2229
|
September 2007 |
£2680 |
16.45 % |
Enzymes
US industry forecasts to 2010 & 2015
|
July 2006 |
£2135 |
16.1 % |
Nanotechnology in Life Science Applications
|
October 2005 |
£2255 |
15.75 % |
Roche Deals
Partneringdesk briefing
|
July 2005 |
£215 |
15.5 % |
Animal Biotechnology
Technologies, Markets and Companies
|
March 2008 |
£1240 |
15.4 % |
Epigenomics
Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics
|
March 2007 |
£2410 |
15.05 % |
Life Science Tools and Technologies for Bio-Pharma R&D
Instruments, Tech Platforms, Informatics and Market
|
March 2003 |
£740 |
15.05 % |
A New Paradigm for Clinical Development
The Clinical Trial in 2015
|
November 2005 |
£1945 |
14.7 % |
Clinical Laboratory Testing Volume 2: Business Strategies
|
March 2007 |
£990 |
14.7 % |
Key Diagnostic Testing Markets
|
December 2004 |
£990 |
14.35 % |
Bayer Schering Pharma Ag
PharmaVitae Profile
|
July 2008 |
£2995 |
14 % |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
|
January 2008 |
£1499 |
13.3 % |
Nutrigenomics
Impacts on Markets, Diets, and Health
|
June 2005 |
£1950 |
13.3 % |
Genzyme Corporation Deals
Partneringdesk briefing
|
July 2005 |
£215 |
13 % |
Protein Therapeutics Market; The
The Science and Business of a Growing Sector
|
June 2006 |
£1970 |
12.95 % |
Nanomedicine 2006-2011
|
June 2006 |
£1499 |
12.25 % |
Commercial Insight Top 20 Cancer Therapeutics
|
July 2006 |
£8695 |
11.9 % |
Taq Wars; The
Competitive Intelligence on How to Survive
|
November 2005 |
£2235 |
11.2 % |
Biomarkers
|
January 2008 |
£1645 |
11.2 % |
Modern Biopharmaceuticals
Design, Development and Optimization, 4 Volumes
|
September 2005 |
£440 |
10.85 % |
United States in Vitro Diagnostics Industry Report
Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits
|
May 2008 |
£1515 |
10.85 % |
Commercial and Pipeline Insight: Systemic antifungals
|
November 2007 |
£7600 |
10.85 % |
Personalized Medicine
Scientific & Commercial Aspects
|
March 2008 |
£1740 |
10.5 % |
The Executive Guide to Molecular Imaging
|
July 2007 |
£595 |
10.15 % |
United Kingdom Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
9.8 % |
Proteomics
Technologies, Markets and Companies
|
March 2008 |
£1740 |
7.7 % |
Gene Therapy
Technologies, Markets and Companies
|
March 2008 |
£1740 |
6.3 % |
|
|
|
|
